Does a prolonged QT peak identify left ventricular hypertrophy in hypertension?

International Journal of Cardiology

Volumn 89, Issue 2-3, 2003, Pages 179-186

  Wong, K Y K ^a   Lim, P O ^a   Wong, S Y S ^a   MacWalter, R S ^a   Struthers, A D ^a   MacDonald, T M ^a  

^a NINEWELLS HOSPITAL   (United Kingdom)

Author keywords

Hypertension; Left ventricular hypertrophy; QT peak

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIGITALIZATION; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; MALE; PILOT STUDY; PREDICTION; PRIORITY JOURNAL; QRS COMPLEX; QT INTERVAL; RECEIVER OPERATING CHARACTERISTIC; SINGLE BLIND PROCEDURE; T WAVE;

EID: 0038736803     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(02)00473-4     Document Type: Article

References (22)

1. Kannel W.B., Gordon T., Offutt D. Left ventricular hypertrophy by electrocardiogram. Prevalence, incidence, and mortality in the Framingham study. Ann Intern Med. 71:1969;89-105.
2. Levy D., Garrison R.J., Savage D.D., Kannel W.B., Castelli W.P. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 322:1990;1561-1566.
3. Verdecchia P., Schillaci G., Borgioni C., Ciucci A., Gattobigio R., Zampi I., et al. Prognostic significance of serial changes in left ventricular mass in essential hypertension. Circulation. 97:1998;48-54.
4. Barr C.S., Naas A., Freeman M., Lang C.C., Struthers A.D. QT dispersion and sudden unexpected death in chronic heart failure. Lancet. 343:1994;327-329.
5. de Bruyne M.C., Hoes A.W., Kors J.A., Hofman A., van Bemmel J.H., Grobbee D.E. QTc dispersion predicts cardiac mortality in the elderly: the Rotterdam Study. Circulation. 97:1998;467-472.
6. Clarkson P.B., Naas A.A., McMahon A., MacLeod C., Struthers A.D., MacDonald T.M. QT dispersion in essential hypertension. QJM. 88:1995;327-332.
7. Lim P.O., Nys M., Naas A.A., Struthers A.D., Osbakken M., MacDonald T.M. Irbesartan reduces QT dispersion in hypertensive individuals. Hypertension. 33:1999;713-718.
8. Wong K.Y.K., MacWalter R.S., Douglas D., Fraser H.W., Ogston S.A., Crombie I., Kendrick S., Struthers A.D. Can the QTc of a single lead predict cardiac death? Scott Med J. 46:2001;26-27.
9. Wong K.Y.K., MacWalter R.S., Douglas D., Fraser H.W., Struthers A.D. Does QT peak predict cardiac death following stroke? Stroke. 31:(Suppl):2000;32.
10. Lee K.W., Okin P.M., Kligfield P., Stein K.M., Lerman B.B. Precordial QT dispersion and inducible ventricular tachycardia. Am Heart J. 134:1997;1005-1013.
11. Sahn D.J., DeMaria A., Kisslo J., Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation. 58:1978;1072-1083.
12. Devereux R.B., Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation. 55:1977;613-618.
13. Devereux R.B., Alonso D.R., Lutas E.M., Gottlieb G.J., Campo E., Sachs I., et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 57:1986;450-458.
14. Sokolow M., Lyon T.P. The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. Am Heart J. 37:1949;161-186.
15. Sahu P., Lim P.O., Rana B.S., Struthers A.D. QT dispersion in medicine: electrophysiological holy grail or fool's gold? QJM. 93:2000;425-431.
16. Liao Y., Cooper R.S., McGee D.L., Mensah G.A., Ghali J.K. The relative effects of left ventricular hypertrophy, coronary artery disease, and ventricular dysfunction on survival among black adults. J Am Med Assoc. 273:1995;1592-1597.
17. Perlini S., Muiesan M.L., Cuspidi C., Sampieri L., Trimarco B., Aurigemma G.P., et al. Midwall mechanics are improved after regression of hypertensive left ventricular hypertrophy and normalization of chamber geometry. Circulation. 103:2001;678-683.
18. Kannel W.B. Left ventricular hypertrophy as a risk factor in arterial hypertension. Eur Heart J. 13:(Suppl D):1992;82-88.
19. Francis C.M., Caruana L., Kearney P., Love M., Sutherland G.R., Starkey I.R., et al. Open access echocardiography in management of heart failure in the community. Br Med J. 310:1995;634-636.
20. Michel B.C., Al M.J., Remme W.J., Kingma J.H., Kragten J.A., van Nieuwenhuizen R., et al. Economic aspects of treatment with captopril for patients with asymptomatic left ventricular dysfunction in The Netherlands. Eur Heart J. 17:1996;731-740.
21. Finkler S.A. The distinction between cost and charges. Ann Intern Med. 96:1982;102-109.
22. Darbar D., Cherry C.J., Kerins D.M. QT dispersion is reduced after valve replacement in patients with aortic stenosis. Heart. 82:1999;15-18.